Medical Xpress·4 min read·hard
Fibronectin pathway may drive Marfan aortic damage, opening new drug targets
S
Spanish National Research Council
✦AI Summary
Researchers have identified a molecular pathway involving the protein fibronectin that contributes to aortic damage in Marfan syndrome. This discovery offers potential new targets for pharmacological treatments to prevent aortic rupture.
edited by Gaby Clark , reviewed by Andrew Zinin
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in